Trials / Completed
CompletedNCT00887484
A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne
A Single-blind, Randomized, Comparative Pilot Study Evaluating the Tolerability of Two Topical Combination Therapies in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Stiefel, a GSK Company · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the tolerability of topical combination therapies in the treatment of facial acne.
Detailed description
The purpose of this study is to compare the tolerability of topical combination therapies in the treatment of facial acne.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BENZOYL PEROXIDE/ CLINDAMYCIN | Commencing at baseline, subjects will apply once daily both treatment arm #1 and treatment arm #2 in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. At 2 weeks, subjects will apply benzoyl peroxide/clindamycin gel to the entire face for an additional 6 weeks. |
| DRUG | BENZOYL PEROXIDE/ ADAPALENE | Commencing at baseline, subjects will apply once daily both treatment arm #1 and treatment arm #2 in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. At 2 weeks, subjects will apply benzoyl peroxide/clindamycin gel to the entire face for an additional 6 weeks. |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-04-24
- Last updated
- 2016-12-13
- Results posted
- 2012-10-23
Locations
4 sites across 1 country: Argentina
Source: ClinicalTrials.gov record NCT00887484. Inclusion in this directory is not an endorsement.